TNSN98120A1 - 5 - (2-ethyle - 2h-tetrazole - 5yl) - 1 - methyle - 1,2,3,6 - tetrahydropuridine. - Google Patents
5 - (2-ethyle - 2h-tetrazole - 5yl) - 1 - methyle - 1,2,3,6 - tetrahydropuridine.Info
- Publication number
- TNSN98120A1 TNSN98120A1 TNTNSN98120A TNSN98120A TNSN98120A1 TN SN98120 A1 TNSN98120 A1 TN SN98120A1 TN TNSN98120 A TNTNSN98120 A TN TNSN98120A TN SN98120 A TNSN98120 A TN SN98120A TN SN98120 A1 TNSN98120 A1 TN SN98120A1
- Authority
- TN
- Tunisia
- Prior art keywords
- ethyle
- tetrazole
- tetrahydropuridine
- methyle
- phrmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
LA PRESENTE INVENTION SE RAPPORTE A UN SEL D'ADDITION D'ACIDE MALEATE DE 5-(2-ETHYLE-2H- TETRAZOLE-5YL)-1-METHYLE-1,2,3,6- TETRAHYDROPYRIDINE, AUX COMPOSITIONS PHRMACEUTIQUES CONTENANT LE SEL D'ADDITION ACIDE ET L'UTILISATION DE CETTE SOURCE POUR LE TRAITEMENT DES TROUBLES PROVOQUES PAR LE DYSFONCTIONNEMENT DE L'ACETHYLCHOLINE (AcCH) OU DU SYSTEME MUSCARINIQUE.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK78197 | 1997-07-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN98120A1 true TNSN98120A1 (fr) | 2005-03-15 |
Family
ID=8097489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNTNSN98120A TNSN98120A1 (fr) | 1997-07-01 | 1998-06-30 | 5 - (2-ethyle - 2h-tetrazole - 5yl) - 1 - methyle - 1,2,3,6 - tetrahydropuridine. |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0994869A1 (fr) |
| JP (1) | JP2002507215A (fr) |
| KR (1) | KR20010014297A (fr) |
| CN (1) | CN1261361A (fr) |
| AR (1) | AR013096A1 (fr) |
| AU (1) | AU735751B2 (fr) |
| BG (1) | BG103933A (fr) |
| BR (1) | BR9810331A (fr) |
| CA (1) | CA2293324A1 (fr) |
| CO (1) | CO4940483A1 (fr) |
| EA (1) | EA200000081A1 (fr) |
| HU (1) | HUP0002876A2 (fr) |
| IL (1) | IL133093A0 (fr) |
| IS (1) | IS5278A (fr) |
| JO (1) | JO2031B1 (fr) |
| MA (1) | MA25138A1 (fr) |
| NO (1) | NO996580L (fr) |
| PE (1) | PE116099A1 (fr) |
| PL (1) | PL337184A1 (fr) |
| SK (1) | SK187399A3 (fr) |
| TN (1) | TNSN98120A1 (fr) |
| TR (1) | TR199903283T2 (fr) |
| UY (2) | UY25069A1 (fr) |
| WO (1) | WO1999001448A1 (fr) |
| ZA (1) | ZA985498B (fr) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
| TR199800801T2 (xx) * | 1995-11-06 | 1998-08-21 | H. Lund-Beck A/S | Travmatik beyin yaralanmalar�n�n tedavisi. |
-
1998
- 1998-06-18 AR ARP980102925A patent/AR013096A1/es not_active Application Discontinuation
- 1998-06-24 ZA ZA985498A patent/ZA985498B/xx unknown
- 1998-06-25 JO JO19982031A patent/JO2031B1/en active
- 1998-06-25 PE PE1998000563A patent/PE116099A1/es not_active Application Discontinuation
- 1998-06-26 CO CO98036576A patent/CO4940483A1/es unknown
- 1998-06-29 UY UY25069A patent/UY25069A1/es not_active Application Discontinuation
- 1998-06-30 TN TNTNSN98120A patent/TNSN98120A1/fr unknown
- 1998-07-01 EP EP98930655A patent/EP0994869A1/fr not_active Withdrawn
- 1998-07-01 BR BR9810331-8A patent/BR9810331A/pt not_active Application Discontinuation
- 1998-07-01 CA CA002293324A patent/CA2293324A1/fr not_active Abandoned
- 1998-07-01 TR TR1999/03283T patent/TR199903283T2/xx unknown
- 1998-07-01 JP JP50616699A patent/JP2002507215A/ja active Pending
- 1998-07-01 MA MA25155A patent/MA25138A1/fr unknown
- 1998-07-01 EA EA200000081A patent/EA200000081A1/ru unknown
- 1998-07-01 AU AU81020/98A patent/AU735751B2/en not_active Ceased
- 1998-07-01 CN CN98806497A patent/CN1261361A/zh active Pending
- 1998-07-01 SK SK1873-99A patent/SK187399A3/sk unknown
- 1998-07-01 HU HU0002876A patent/HUP0002876A2/hu unknown
- 1998-07-01 KR KR1019997012429A patent/KR20010014297A/ko not_active Application Discontinuation
- 1998-07-01 PL PL98337184A patent/PL337184A1/xx unknown
- 1998-07-01 WO PCT/DK1998/000294 patent/WO1999001448A1/fr not_active Application Discontinuation
- 1998-07-01 IL IL13309398A patent/IL133093A0/xx unknown
- 1998-09-10 UY UY25177A patent/UY25177A1/es not_active Application Discontinuation
-
1999
- 1999-11-30 IS IS5278A patent/IS5278A/is unknown
- 1999-11-30 BG BG103933A patent/BG103933A/xx unknown
- 1999-12-30 NO NO996580A patent/NO996580L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PE116099A1 (es) | 1999-11-23 |
| JP2002507215A (ja) | 2002-03-05 |
| CO4940483A1 (es) | 2000-07-24 |
| BG103933A (en) | 2000-07-31 |
| CA2293324A1 (fr) | 1999-01-14 |
| IS5278A (is) | 1999-11-30 |
| AR013096A1 (es) | 2000-12-13 |
| SK187399A3 (en) | 2000-06-12 |
| NO996580D0 (no) | 1999-12-30 |
| HUP0002876A2 (hu) | 2001-06-28 |
| CN1261361A (zh) | 2000-07-26 |
| TR199903283T2 (xx) | 2000-06-21 |
| AU735751B2 (en) | 2001-07-12 |
| AU8102098A (en) | 1999-01-25 |
| NO996580L (no) | 1999-12-30 |
| JO2031B1 (en) | 1999-05-15 |
| BR9810331A (pt) | 2000-09-05 |
| MA25138A1 (fr) | 2001-04-02 |
| PL337184A1 (en) | 2000-08-14 |
| EP0994869A1 (fr) | 2000-04-26 |
| UY25069A1 (es) | 1998-12-21 |
| WO1999001448A1 (fr) | 1999-01-14 |
| UY25177A1 (es) | 2000-12-29 |
| EA200000081A1 (ru) | 2000-08-28 |
| ZA985498B (en) | 1999-01-20 |
| IL133093A0 (en) | 2001-03-19 |
| KR20010014297A (ko) | 2001-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN01126A1 (fr) | Imidazoles substitues nouveaux, procede pour leur preparation et compositions les contenant | |
| TNSN99110A1 (fr) | Inhibiteurs non peptidiques de l'adhesion cellulaire sous la dependance de vla-4, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| BG106771A (en) | Heterocyclic substituted pyrazolones | |
| TNSN98104A1 (fr) | Agonistes de prostaglandines, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| TNSN99039A1 (fr) | Bicyclo [2.2.1] heptanes nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA32655B1 (fr) | Composés modulant sélectivement le récepteur cb2 | |
| TNSN99006A1 (fr) | 4-(2-ceto-1-benzimidazolinyl) piperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| TNSN98084A1 (fr) | Derives de macrolides substitues en position c-4 | |
| FR2393573A1 (fr) | Preparations capillaires contenant un copolymere de vinylpyrrolidone | |
| TNSN98036A1 (fr) | Derives d'acide hexanoique nouveaux | |
| MA26697A1 (fr) | Composes nouveaux inhibiteurs de gsk-3 et compositions pharmaceutiques les contenant | |
| TNSN99126A1 (fr) | Pyrrolopyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| TNSN98182A1 (fr) | Agonistes de prostaglandines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| TNSN99236A1 (fr) | Derives bicycliques substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| EP0786995A4 (fr) | ||
| MA28093A1 (fr) | Forme polymorphe de 3-phenylsulfonyl-8-piperazine-1-yl-quinoleine | |
| TNSN98227A1 (fr) | Association pharmaceutique pour le traitement d'un dysfonctionnement sexuel et compositions la contenant. | |
| TNSN99001A1 (fr) | Indoles 2,3-substitues servant d'agents anti-inflammatoires et analgesiques | |
| TNSN01046A1 (fr) | Ethers de diphenyle utiles en therapeutique | |
| TNSN96174A1 (fr) | Azetidines, procede pour leur preparation, et compositions pharmaceutiques les contenant. | |
| MA26741A1 (fr) | Suspensions de ziprasidone nouvelles et procede pour leur preparation. | |
| TNSN99013A1 (fr) | Derives d'acide dihydroxyhexanoique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| TNSN97039A1 (fr) | Derives d'oxadiazole et de thiadiazole antagonistes des recepteurs muscariniques. | |
| TNSN99056A1 (fr) | Composes azabicycliques substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| TNSN00106A1 (fr) | Composition pharmaceutique nouvelle comprenant un inhibiteur de nos, et procede pour sa preparation |